KK
TXG icon

KLP Kapitalforvaltning’s 10x Genomics TXG Stock Holding History

KLP Kapitalforvaltning’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$889K Sell
23,200
-20,300
-47% -$532K ﹤0.01% 1192
2026
Q1 		$924K Buy
43,500
+21,500
+98% +$430K ﹤0.01% 1073
2025
Q4 		$359K Buy
22,000
+2,700
+14% +$40.8K ﹤0.01% 1579
2025
Q3 		$226K Hold
19,300
– – ﹤0.01% 1780
2025
Q2 		$223K Hold
19,300
– – ﹤0.01% 1741
2025
Q1 		$168K Hold
19,300
– – ﹤0.01% 1821
2024
Q4 		$277K Buy
+19,300
New +$305K ﹤0.01% 1685

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KLP Kapitalforvaltning's TXG Position: Q2 2026 in Review

KLP Kapitalforvaltning reduced its 10x Genomics (TXG) stake by 47% in Q2 2026, selling an estimated $532K and leaving 23,200 shares worth $889K. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

KLP Kapitalforvaltning first reported a position in TXG in Q4 2024 and has held it in 7 quarters since. The position peaked at $924K in Q1 2026. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • KLP Kapitalforvaltning held 23,200 shares of 10x Genomics worth $889K as of Q2 2026.
  • KLP Kapitalforvaltning sold 20,300 10x Genomics shares in Q2 2026, an estimated $532K.
  • 10x Genomics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1192 holding.
  • KLP Kapitalforvaltning first reported a position in 10x Genomics in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's 10x Genomics position peaked at $924K in Q1 2026.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.